The Centre for Tropical Medicine and Global Health is a world leading Centre within the Nuffield Department of Clinical Medicine, University of Oxford, comprised of research groups who are permanently based in Africa and Asia as well as across two sites in Oxford. Our research ranges from clinical studies to behavioral sciences, with capacity building integral to all of our activities.
Our research is conducted at three Wellcome Trust Major Overseas Programmes in Kenya, Thailand and Viet Nam as well as a growing Centre in Oxford. The Centre for Tropical Medicine and Global Health also brings together a number of sister groups in Laos, Tanzania, Indonesia, the Democratic Republic of Congo, Myanmar, Cambodia and Nepal, as well as multiple collaborators around the world.
Tackling infectious diseases, which kill many millions of people every year, is one of the greatest challenges of the 21st century. We are researching solutions to the increasingly urgent problems these diseases cause.
The MSc in International Health and Tropical Medicine provides a multidisciplinary and interdisciplinary foundation in global health. This exciting new course embraces the breadth and complexity of global health challenges facing resource limited contexts and equips candidates with the tools and awareness to contribute to innovative solutions.
Fighting malaria is one of our major objectives. Many NDM scientists try to find new ways to help the millions of people worldwide who are affected by malaria. In our edutainment game, players role-play as mosquito or malaria parasite, and interact with different stages of the disease's life-cycle.
9th February 2016, Mae Sot (Thailand) – Artemisinins, the most effective antimalarials available, should be endorsed in the first trimester of pregnancy to ensure optimal treatment of falciparum malaria in pregnant women, reports a paper published today in The Lancet Infectious Diseases.
Children living in Kenya are well protected from life-threatening infections such as meningitis, sepsis and pneumonia caused by the bacteria Haemophilus influenzae type b (Hib), by the existing three-dose vaccine regime.
A 15-year study carried out in KEMRI| Wellcome Trust Research Programme in Kilifi, Kenya and funded by the Wellcome Trust and Gavi, the Vaccine Alliance has shown that there is no need to give a Hib booster to toddlers to extend immunity into later childhood. The study provides the evidence public health officials need to be confident that Hib spread and infection in Kenya is under control.
Zika virus is a rapidly emerging vector-born flavivirus, with potential to spread to new areas where the vector Aedes mosquitos are present.
The aim of the website, developed by the International Severe Acute Respiratory and Infection Consortium (ISARIC) and hosted by the Global Health Network (tGHN), is to provide a platform for sharing and developing research priorities, protocols and data capture systems alongside the latest epidemiological and clinical management information about Zika infection.
[Photo: Prof. Frank Hadley Collins, Dir., Cntr. for Global Health and Infectious Diseases, Univ. of Notre Dame, CDC. Aedes Aegypti mosquito feeding.]
Understanding the variation of malaria risk between houses, villages or region, and how malaria is transmitted in and around that variability helps develop better malaria control programmes and use their resources more wisely. Since malaria control tools are becoming less effective with time, progress in vaccine design is essential, as explained by Professor Philip Bejon.
In Blueprint this month: How researchers from the Centre for Tropical Medicine and Global Health, including Professors Peter Horby and Trudie Lang, took a leading role in the research response against Ebola at the height of the crisis.
Did you know that as part of Oxford University's Campaign, you can donate directly to Tropical Medicines unit on the Thai-Myanmar border?